Wolf359f wrote: » Just going by the Scottish slide Nicola Sturgeon showed weeks ago, adjusted to equal distribution throughout the UK, up to the end of Jan, the end of 2020, the UK received 5.7mil Pfizer, in Jan 2021 that was 3mil. Then we have the 8mil from Feb that has been leaked or announced Total to the end of Feb: 16.7mil So 16.7mil out of a total of ~24mil, would make it the most common vaccine in the UK (that's ignoring any Pfizer used so far in March)
Pete_Cavan wrote: » That's not an insignificant number if all are vaccined outside the national programme, though obviously it only reduces the timeline for full vaccination by a few hours. If those people aren't transmitting the virus, as data suggests, it is a help. Hopefully J&J do the same.
Rebelbrowser wrote: » I still think its possible the UK will be in a worse position than EU countries by years end because AZ will prove not to be as good with variants / not as good at stopping transmission / not as long lasting as Pfizer.
hmmm wrote: » https://twitter.com/sailorrooscout/status/1370378272282980352
is_that_so wrote: » Good to see! Pity we can't get any to see for ourselves! Why Syrian hamsters, though?
Hardyn wrote: » Because their immune responses to pathogens are quite similar to that of humans.
What news article? You said "someone on the internet said"
RavenBea17b wrote: » All, Does anyone have a link/source that looks at each countries geo sequence for covid variant, capabilities, current rate of sequencing, plus plan to increase variant awareness, so adjusting vaccines etc. I know that Denmark carries out a large percentage of checks per positives, UK too. I think the last figure I saw mentioned for USA was something like 2.5 -3% with an aim to get to 6%. I guess it everywhere will be ramping up. How much is carried out in Ireland do we know ? With the first Danish variant (in mink) then Kent, South Africa, Brasil, Californian, NYC etc, it will be important step in developing adjusting testing and vaccines.
noserider wrote: » Irish Examiner Thu, 11 Mar, 2021 - 08:04 Jane Kirby, PA Health Editor A monoclonal antibody drug reduces hospital admission or death from Covid-19 by 85%, the pharmaceutical giant GlaxoSmithKline (GSK) has announced. The drug, called VIR-7831, is a new treatment for people with mild to moderate illness, and the study has been so successful that it has been stopped early. GSK and its partner, Vir Biotechnology, plan to immediately seek an emergency use authorisation in the United States and approval in other countries, including potentially in the UK. Monoclonal antibodies are laboratory-produced molecules that mimic human antibodies. The global phase 3 clinical trial based its initial analysis on data from 583 patients at risk of hospital admission. GSK said VIR-7831 works in two ways – by blocking the virus’s entry into healthy cells and also clearing infected cells. A separate laboratory study has found that VIR-7831 is effective against the main current Covid-19 variants, including the Kent, South African and Brazilian variants, the firm said. VIR-7831 is designed to be given as a single intravenous (IV) infusion. Dr Hal Barron, chief scientific officer at GSK, said: “We are pleased that this unique monoclonal antibody was able to bring such a profound benefit to patients. “We look forward to the possibility of making VIR-7831 available to patients as soon as possible and to further exploring its potential in other settings.” A trial using the drug in very sick patients in hospital was stopped last week owing to lack of benefit.
LuckyLloyd wrote: » This is unbelievable news...why isn't it getting more attention?
Kivaro wrote: » Possibly because of the last line in your quote: "A trial using the drug in very sick patients in hospital was stopped last week owing to lack of benefit."
Apogee wrote: » https://twitter.com/FergalBowers/status/1370422008320778248
is_that_so wrote: » It's a possible treatment for people with COVID rather than a vaccine. It's also unapproved for now. EMA are doing rolling reviews of two other such treatments.
stephenjmcd wrote: » MM says his meeting with AZ CEO is due to take place tonight
quartz1 wrote: » MM on RTE News giving an interview but saying absolutely nothing of any consequence . The words are coming out of his mouth but they mean nothing .
braychelsea wrote: » Only silver lining about AZ not delivering is more people getting the more effective mRNA vaccines
landofthetree wrote: » The real world data show all the vaccines are excellent. It's not really a positive at all.
Elessar wrote: » 2nd dose of AZ vaccine now to be given up to 12 weeks after 1st, allowing more people to get their first shot:https://www.independent.ie/irish-news/politics/astrazeneca-vaccine-dose-intervals-to-be-stretched-to-allow-for-more-people-to-receive-first-jab-40188401.html
braychelsea wrote: » Never said it was a positive or that AZ wasn't effective. All vaccines seems to eradicate death/hospitalisation. Just that more people will receive a vaccine with higher efficacy which will lead to less transmission long-term. Pfizer prevents transmission by 94% compare to AZ at ~ 50%.
brickster69 wrote: » Third wave starts in Germanyhttps://www.cnbc.com/2021/03/12/germany-declares-a-covid-third-wave-has-begun-italy-set-for-easter-lockdown.html?__source=iosappshare%7Ccom.apple.UIKit.activity.PostToTwitter
![Photo of [Deleted User]](https://wc.vanillicon.com/v2/c8f64116a02fb35bb4652b6f11c7f3cf.svg)
